focus -WSS

focus

author：hotspot 2025-09-29 01:35:47 - browse：18

Balance innovation — Medicare laid out in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be. Adobe

WASHINGTON — Medicare laid out Wednesday in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be.

Democrats outlined some parts of the process in the Inflation Reduction Act that passed Congress last August, but the details of how drugs will be selected and what factors will be considered have been vague until now. Though the actual negotiated prices won’t take effect for years, Medicare officials must announce the first 10 drugs they’ll negotiate over by Sept. 1.

The guidance clarifies that the agency will choose the 50 pharmacy drugs that cost Medicare the most money, based on gross expenditures. If drugs have the same cost to the program, then the one that has been approved longer will be ranked higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： FTC falls short on scrutinizing hospital mergers, study says

WSS

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Emergency workers more likely to restrain Black patients: study

Cancer researcher Catriona Jamieson is sending tumors into space

It's been 20 years since Dolly the sheep. Where's my clone?

Medical student insurance fails on mental health care coverage

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

hotspot

focus

focus

Peter Hotez and the public health issue of online harassment

Thermo Fisher plant for manufacturing gene therapies to expand

The cancer drug shortage isn’t new — and neither are the solutions

Hearing on Medicare drug price negotiation gets unusually heated

ChatGPT in medicine: STAT answers readers' burning questions

What Congress can do to address the rural doctor shortage

Hepatitis C has a cure — but many Americans still lack access to it

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Virginia high school admissions case could be legal follow

MultiPlan and major insurers sued for alleged medical price

focus

H5N1 bird flu virus started spreading in cows in Texas in December

Element Biosciences CEO lays out genome sequencing strategy

CDC advisers recommend seasonal use of Pfizer RSV shot

Biotech stock slump in 2023: awaiting the turnaround

Q&A: Jennifer Adair on making gene therapy available globally

How AI helped researchers track recovery from depression

hotspot

leisure time

hotspot

hotspot